Secukinumab's safety and effectiveness in treating Hidradenitis Suppurativa are discussed by Raj Chovatiya, MD, PhD.

Published Date: 21 Jan 2024

Following secukinumab's FDA approval for the treatment of hidradenitis suppurativa, Dr. Chovatiya covered some of the most important safety information in this section of his interview.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

2.

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

3.

We Don't Always Know What's 'Best' for Our Patients

4.

Should the UK introduce targeted prostate cancer screening? The case for and against

5.

Germline Profiling May Improve Risk Stratification in t-MNs


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot